Status:

COMPLETED

Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk

Lead Sponsor:

University College Cork

Conditions:

Hypertension

Eligibility:

All Genders

50-65 years

Phase:

NA

Brief Summary

Heart disease and stroke are the most common cause of death in Ireland today.One of the main risk factors for heart disease and stroke is high blood pressure or hypertension. Research has found that c...

Detailed Description

Poor dietary habits of Irish adults has been accompanied by epidemics of obesity and metabolic disorders such as type II diabetes leading to a substantial predicted increase in the prevalence of chron...

Eligibility Criteria

Inclusion

  • Male and female
  • Non-diabetic
  • Aged 50-65
  • BMI 25-35kg/m²
  • Mild hypertensive: Blood pressure 130-149 mmHg

Exclusion

  • Current smoker
  • Diagnosed hypertensive
  • History of cardiovascular disease
  • Diabetic
  • Chronic kidney disease
  • Gastrointestinal disease
  • Currently on anti-hypertensive medications
  • Allergic to eggs

Key Trial Info

Start Date :

April 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2016

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT02223169

Start Date

April 1 2014

End Date

February 1 2016

Last Update

May 3 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

School of Food and Nutritional Sciences, UCC

Cork, Ireland

2

University College Cork

Cork, Ireland

Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk | DecenTrialz